应用精密过滤输液器输注抗肿瘤辅助用药的临床观察  被引量:6

Intravenous injection of anti-cancer adjuvant drugs by precise filtering infusion apparatus

在线阅读下载全文

作  者:魏少美[1] 董寒玉[1] 马其冬 

机构地区:[1]蚌埠医学院第一附属医院肿瘤内科,安徽蚌埠233004

出  处:《蚌埠医学院学报》2014年第9期1299-1301,共3页Journal of Bengbu Medical College

摘  要:目的:探讨应用精密过滤输液器减少抗肿瘤辅助用药所致的输液反应和静脉炎的效果。方法:将306例静脉输注抗肿瘤辅助用药的恶性肿瘤患者随机分为观察组150例和对照组156例。观察组使用一次性精密过滤输液器输液,对照组使用一次性普通输液器输液。比较2组患者输液过程中输液反应和静脉炎的发生情况。结果:观察组与对照组输液反应的总发生率分别为6.7%和21.1%,静脉炎的总发生率分别为7.3%和26.9%。观察组输液反应和静脉炎的发生率均显著低于对照组(P〈0.05~P〈0.01);观察组静脉炎的程度较对照组明显减轻(P〈0.01)。结论:使用精密过滤输液器能有效减少抗肿瘤辅助用药所致输液反应和静脉炎的发生。Objective:To investigate the effect of precise filtering infusion in reducing the infusion reaction and phlebitis induced by anti-cancer adjuvant drugs. Methods:A total of 306 cancer patients receiving intravenous infusion of anti-cancer adjuvant drugs were randomly divided into observation group ( 150 cases ) and control group ( 156 cases ) . The patients in the observation group used disposable precise filtering infusion apparatus and the patients in the control group ordinary syringe injection. The incidence of infusion reaction and phlebitis in the two groups was observed and compared. Results:The total incidence of infusion reaction was 6. 7% and 21. 1% in the observation group and the control group,respectively;the total incidence of phlebitis was 7. 3% and 26. 9% in the observation group and the control group, respectively. The incidence of infusion reaction and phlebitis in the observation group was significantly lower than that in the control group(P〈0. 05 to P〈0. 01);the phlebitis in the observation group was relieved significantly (P〈0. 01). Conclusions:Application of precise filtering infusion apparatus can effectively reduce the occurrence of infusion reaction and phlebitis induced by intravenous injection of anti-cancer adjuvant drugs.

关 键 词:输液疗法 精密过滤输液器 抗肿瘤辅助用药 输液反应 静脉炎 

分 类 号:R826.26[医药卫生—临床医学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象